INV-12APPP
Teaching hospital + biotech
- Capital
- $2.20B
- Direct jobs
- 9,400
- Indirect
- 14,000
- IRR target
- 11%
- ROI band
- 9–12%
- Payback
- 13 yr
- Stage
- S3
- ESG
- 94/100
12-year delivery timeline
Feasibility & EIA
Y0.0–Y0.5
Master design
Y1.0–Y2.0
Financing close
Y2.0–Y3.0
Site mobilisation
Y3.0–Y4.0
Vertical construction
Y3.5–Y6.0
Commissioning
Y5.5–Y7.0
Operations & stabilization
Y7.0–Y12.0
Sensitivity · best / base / worst12-yr horizon · 10% discount
| Case | IRR | ROI band | Payback | MOIC | NPV |
|---|---|---|---|---|---|
| worst | -6% | -8–-4% | 12 yr | 0.57× | $-1.92B |
| base | 1.2% | -0.8–3.2% | 12 yr | 1.11× | $-1.07B |
| best | 6% | 4–8% | 12 yr | 1.64× | $-515M |
Capex variance
1.20×1.00×0.92×
Operating cost variance
1.15×1.00×0.93×
Demand / utilisation
0.80×1.00×1.15×
Exit / terminal value
0.85×1.00×1.20×
FX & macro stability
0.92×1.00×1.05×
